<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药代表 | wechat-feeds</title><link>http://MjM5OTIxMzY2MA.favicon.privacyhide.com/favicon.ico</link><description>本号为正版MRCLUB「医药代表」公众号，谨防山寨！——医药行业的那些事儿，医药推广技能，内部招聘信息，业界资讯推送，50万医药代表会员及企业管理人员每天从我们这获得职业指导及从业资讯。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 01 May 2021 07:24:47 +0800</pubDate><image><url>http://MjM5OTIxMzY2MA.favicon.privacyhide.com/favicon.ico</url><title>医药代表 | wechat-feeds</title><link>http://MjM5OTIxMzY2MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>19种国谈药品哪些医院已有？医保局可查了！</title><link>https://mp.weixin.qq.com/s/HOCQq07AKFFbolGFWhMwzA</link><description></description><content:encoded><![CDATA[19种国谈药品哪些医院已有？医保局可查了！]]></content:encoded><pubDate>Fri, 30 Apr 2021 23:21:21 +0800</pubDate></item><item><title>“八省二区”带量采购开始，21个品种！</title><link>https://mp.weixin.qq.com/s/xuJRxyD7b26goS8brpv4cw</link><description></description><content:encoded><![CDATA[“八省二区”带量采购开始，21个品种！]]></content:encoded><pubDate>Fri, 30 Apr 2021 23:21:21 +0800</pubDate></item><item><title>又一轮药企“大乱斗”要来了，53个品种！</title><link>https://mp.weixin.qq.com/s/1nBnRF0XdA62Bj56TLFaFg</link><description></description><content:encoded><![CDATA[又一轮药企“大乱斗”要来了，53个品种！]]></content:encoded><pubDate>Thu, 29 Apr 2021 22:58:26 +0800</pubDate></item><item><title>依奇珠单抗最新临床研究数据发布！惠及更多中重度银屑病患者</title><link>https://mp.weixin.qq.com/s/-nJbCv0KS_jYvhYA5f0QcQ</link><description></description><content:encoded><![CDATA[依奇珠单抗最新临床研究数据发布！惠及更多中重度银屑病患者]]></content:encoded><pubDate>Thu, 29 Apr 2021 22:58:26 +0800</pubDate></item><item><title>西安杨森创新靶向药物兆珂®在华获批新适应症</title><link>https://mp.weixin.qq.com/s/X9x1BNvVQKRYqhoF0blwIA</link><description></description><content:encoded><![CDATA[西安杨森创新靶向药物兆珂®在华获批新适应症]]></content:encoded><pubDate>Thu, 29 Apr 2021 22:58:26 +0800</pubDate></item><item><title>将加速上市获批！恒瑞医药卡瑞利珠单抗获美国FDA孤儿药认定</title><link>https://mp.weixin.qq.com/s/qrlkTBSxrvVWcqgvFHwglg</link><description></description><content:encoded><![CDATA[将加速上市获批！恒瑞医药卡瑞利珠单抗获美国FDA孤儿药认定]]></content:encoded><pubDate>Thu, 29 Apr 2021 22:58:26 +0800</pubDate></item><item><title>每人2600元感谢金！又一家医药企业福利来了……</title><link>https://mp.weixin.qq.com/s/D4WuLQfl9ouyh-bskyKiQA</link><description></description><content:encoded><![CDATA[每人2600元感谢金！又一家医药企业福利来了……]]></content:encoded><pubDate>Thu, 29 Apr 2021 22:58:26 +0800</pubDate></item><item><title>国家疾病预防控制局成立！王贺胜出任局长</title><link>https://mp.weixin.qq.com/s/qW4kgpnBs0UWL99T-pZiMg</link><description></description><content:encoded><![CDATA[国家疾病预防控制局成立！王贺胜出任局长]]></content:encoded><pubDate>Wed, 28 Apr 2021 22:02:54 +0800</pubDate></item><item><title>邀你共迎高光时刻！嘉和生物商业化板块全国扩招（附职位）</title><link>https://mp.weixin.qq.com/s/Wb-nxUiQnzyPnqNfvXO0Iw</link><description></description><content:encoded><![CDATA[邀你共迎高光时刻！嘉和生物商业化板块全国扩招（附职位）]]></content:encoded><pubDate>Wed, 28 Apr 2021 22:02:54 +0800</pubDate></item><item><title>央视点赞恒瑞肝癌治疗“双艾”方案，医保覆盖最广PD-1再传捷报！</title><link>https://mp.weixin.qq.com/s/_jZP-D4b8mZPRlLCV8m76A</link><description></description><content:encoded><![CDATA[央视点赞恒瑞肝癌治疗“双艾”方案，医保覆盖最广PD-1再传捷报！]]></content:encoded><pubDate>Wed, 28 Apr 2021 22:02:54 +0800</pubDate></item><item><title>中国抗癌新药泽布替尼传捷报：头对头再证优效与安全性！</title><link>https://mp.weixin.qq.com/s/qOLqimOTcO5Bhg0hZTg_EA</link><description></description><content:encoded><![CDATA[中国抗癌新药泽布替尼传捷报：头对头再证优效与安全性！]]></content:encoded><pubDate>Wed, 28 Apr 2021 22:02:54 +0800</pubDate></item><item><title>【内部招聘772】新增绿谷、赛诺菲、辉瑞、AZ、拜耳、三生、礼来、德琪医药等职位</title><link>https://mp.weixin.qq.com/s/OJuWxfyth7Cg1AfPIS3LJA</link><description></description><content:encoded><![CDATA[【内部招聘772】新增绿谷、赛诺菲、辉瑞、AZ、拜耳、三生、礼来、德琪医药等职位]]></content:encoded><pubDate>Wed, 28 Apr 2021 22:02:54 +0800</pubDate></item><item><title>开始了！八部委发布2021年医疗纠风工作通知！</title><link>https://mp.weixin.qq.com/s/7b1c_JlT7v2rqakUZ2u1ag</link><description></description><content:encoded><![CDATA[开始了！八部委发布2021年医疗纠风工作通知！]]></content:encoded><pubDate>Tue, 27 Apr 2021 23:04:52 +0800</pubDate></item><item><title>升职、涨薪、落户一条龙—医药销售的职场助推器</title><link>https://mp.weixin.qq.com/s/IMbAn6Jhyt6-nfwfFdg-6A</link><description></description><content:encoded><![CDATA[升职、涨薪、落户一条龙—医药销售的职场助推器]]></content:encoded><pubDate>Tue, 27 Apr 2021 23:04:52 +0800</pubDate></item><item><title>全球首个预防用单抗nirsevimab全球三期临床证实：可保护健康婴儿免受呼吸道合胞病毒侵害</title><link>https://mp.weixin.qq.com/s/CoffGNsoX51pXDSfVpX_xg</link><description></description><content:encoded><![CDATA[全球首个预防用单抗nirsevimab全球三期临床证实：可保护健康婴儿免受呼吸道合胞病毒侵害]]></content:encoded><pubDate>Tue, 27 Apr 2021 23:04:52 +0800</pubDate></item><item><title>吉利德科学肝炎事业部负责人确定！他来自罗氏……</title><link>https://mp.weixin.qq.com/s/oC8f9V0M_eZfqIczdG9nXg</link><description></description><content:encoded><![CDATA[吉利德科学肝炎事业部负责人确定！他来自罗氏……]]></content:encoded><pubDate>Tue, 27 Apr 2021 23:04:52 +0800</pubDate></item><item><title>赛诺菲巴斯德在华启动 “优苗人生”计划</title><link>https://mp.weixin.qq.com/s/Chz_mhXXlHseZT8bQRFSMA</link><description></description><content:encoded><![CDATA[赛诺菲巴斯德在华启动 “优苗人生”计划]]></content:encoded><pubDate>Mon, 26 Apr 2021 23:27:06 +0800</pubDate></item><item><title>武田中国抗肿瘤事业部负责人确定！</title><link>https://mp.weixin.qq.com/s/FhsUJ_YkmyYdmZPF3A4ILA</link><description></description><content:encoded><![CDATA[武田中国抗肿瘤事业部负责人确定！]]></content:encoded><pubDate>Mon, 26 Apr 2021 23:27:06 +0800</pubDate></item><item><title>山东公布第四批国采执行日期！</title><link>https://mp.weixin.qq.com/s/Vu-6scEQaQ8hA5tHYKEmVA</link><description></description><content:encoded><![CDATA[山东公布第四批国采执行日期！]]></content:encoded><pubDate>Mon, 26 Apr 2021 23:27:06 +0800</pubDate></item><item><title>安徽省公布第四批国采执行日期！</title><link>https://mp.weixin.qq.com/s/x9XT8O7dVU85-ynHhw512Q</link><description></description><content:encoded><![CDATA[安徽省公布第四批国采执行日期！]]></content:encoded><pubDate>Mon, 26 Apr 2021 23:27:06 +0800</pubDate></item></channel></rss>